KYTHERA, Inc. IPO Advisory

IPO Research - IPO Boutique



Home

Subscriptions



Company
Symbol
Price
Shares
Trade Date
KYTHERA Biopharmaceuticals, Inc.KYTH
[ Nasdaq ]
16.002.2 millionOctober 9 2013
Underwriter(s):
J.P. Morgan, BofA Merrill Lynch, Leerink Swann
Co-Manager(s):
Cowen & Co.
Industry:
Health Care
Employees:
      
Founded:
 
Address:
 
Phone:
 


For IPO Boutique's "scale of 1 to 5" BUY rating on KYTHERA Biopharmaceuticals, Inc., and our comprehensive analysis, click the "Buy Market Research" link above.




IPO Boutique aggregates information on public companies and private companies, such as KYTHERA, Inc. "KYTH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.




Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.



Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2014 IPO Boutique. All Rights Reserved